skip to Main Content

Roche reach out to TreatSMA to provide assurances regarding Risdiplam

  • 28 April 2020

Last weekend we announced on our website the changes that Roche were making to their compassion access program in light of Covid-19 challenges. While this was a welcome move we also published a statement questioning the decision not to go further with access. Following that statement we held a call with Roche and their UK Managing Director: We wanted to provide you a summary of that conversation.

Read More

Roche announce changes to compassion access program in light of Covid-19

  • 17 April 2020

We know across the world that people have been struggling to receive their Spinraza treatment because of the coronavirus causing significant hospital capacity and safety issues. Roche today have announced that they are relaxing their compassion access program eligibility criteria to help those who have been affected by this. Statement below:

Read More
Back To Top